mpcr biofire filmarray Search Results


90
BioFire Defense filmarray mpcr
<t> Multiplex PCR </t> and antimicrobial and diagnostic stewardship: key findings
Filmarray Mpcr, supplied by BioFire Defense, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/filmarray mpcr/product/BioFire Defense
Average 90 stars, based on 1 article reviews
filmarray mpcr - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
BioFire Defense broad-panel respiratory mpcr filmarray pneumonia panel plus
Trial design. In the intervention arm, before the end of day 1, clinicians have to consider all the early microbiological results <t>(mPCR</t> FA-PPP, urine antigen assays, blood cultures and Gram stain examination of <t>respiratory</t> tract sample) and procalcitonin before the end of day 1, and subsequently to apply an algorithm of early antibiotics discontinuation or de-escalation (red square). This algorithm is described in . In both arms, at day 3 and day after day until day 7, clinicians are encouraged to consider antibiotic discontinuation, based on procalcitonin values and kinetics. CAP, community-acquired pneumonia; FA-PPP, FilmArray Pneumonia Panel Plus; ICU, intensive care unit; mPCR, multiplex PCR.
Broad Panel Respiratory Mpcr Filmarray Pneumonia Panel Plus, supplied by BioFire Defense, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/broad-panel respiratory mpcr filmarray pneumonia panel plus/product/BioFire Defense
Average 90 stars, based on 1 article reviews
broad-panel respiratory mpcr filmarray pneumonia panel plus - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
BioFire Defense filmarray gi mpcr
<t> Multiplex PCR </t> and antimicrobial and diagnostic stewardship: key findings
Filmarray Gi Mpcr, supplied by BioFire Defense, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/filmarray gi mpcr/product/BioFire Defense
Average 90 stars, based on 1 article reviews
filmarray gi mpcr - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
BioFire Defense mpcr respiratory panel filmarray
Background.
Mpcr Respiratory Panel Filmarray, supplied by BioFire Defense, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mpcr respiratory panel filmarray/product/BioFire Defense
Average 90 stars, based on 1 article reviews
mpcr respiratory panel filmarray - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
BioFire Defense gastrointestinal mpcr filmarray
Background.
Gastrointestinal Mpcr Filmarray, supplied by BioFire Defense, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gastrointestinal mpcr filmarray/product/BioFire Defense
Average 90 stars, based on 1 article reviews
gastrointestinal mpcr filmarray - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
BioFire Defense mpcr assay (filmarray panel rp2)
Background.
Mpcr Assay (Filmarray Panel Rp2), supplied by BioFire Defense, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mpcr assay (filmarray panel rp2)/product/BioFire Defense
Average 90 stars, based on 1 article reviews
mpcr assay (filmarray panel rp2) - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
BioFire Defense mpcr test filmarray 2.1 respiratory panel
Background.
Mpcr Test Filmarray 2.1 Respiratory Panel, supplied by BioFire Defense, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mpcr test filmarray 2.1 respiratory panel/product/BioFire Defense
Average 90 stars, based on 1 article reviews
mpcr test filmarray 2.1 respiratory panel - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
BioFire Defense mpcr testing using the biofire filmarray respiratory panel 2 (rp 2)
Background.
Mpcr Testing Using The Biofire Filmarray Respiratory Panel 2 (Rp 2), supplied by BioFire Defense, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mpcr testing using the biofire filmarray respiratory panel 2 (rp 2)/product/BioFire Defense
Average 90 stars, based on 1 article reviews
mpcr testing using the biofire filmarray respiratory panel 2 (rp 2) - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


 Multiplex PCR  and antimicrobial and diagnostic stewardship: key findings

Journal: Current Infectious Disease Reports

Article Title: Syndromic Multiplex Polymerase Chain Reaction (mPCR) Testing and Antimicrobial Stewardship: Current Practice and Future Directions

doi: 10.1007/s11908-021-00748-z

Figure Lengend Snippet: Multiplex PCR and antimicrobial and diagnostic stewardship: key findings

Article Snippet: The BioFire FilmArray mPCR was 94.7–100% sensitive for these targets, and 98.6–100% specific [ ].

Techniques: Multiplex Assay, Diagnostic Assay, Refining, Infection

Trial design. In the intervention arm, before the end of day 1, clinicians have to consider all the early microbiological results (mPCR FA-PPP, urine antigen assays, blood cultures and Gram stain examination of respiratory tract sample) and procalcitonin before the end of day 1, and subsequently to apply an algorithm of early antibiotics discontinuation or de-escalation (red square). This algorithm is described in . In both arms, at day 3 and day after day until day 7, clinicians are encouraged to consider antibiotic discontinuation, based on procalcitonin values and kinetics. CAP, community-acquired pneumonia; FA-PPP, FilmArray Pneumonia Panel Plus; ICU, intensive care unit; mPCR, multiplex PCR.

Journal: BMJ Open

Article Title: Combined use of a broad-panel respiratory multiplex PCR and procalcitonin to reduce duration of antibiotics exposure in patients with severe community-acquired pneumonia (MULTI-CAP): a multicentre, parallel-group, open-label, individual randomised trial conducted in French intensive care units

doi: 10.1136/bmjopen-2020-048187

Figure Lengend Snippet: Trial design. In the intervention arm, before the end of day 1, clinicians have to consider all the early microbiological results (mPCR FA-PPP, urine antigen assays, blood cultures and Gram stain examination of respiratory tract sample) and procalcitonin before the end of day 1, and subsequently to apply an algorithm of early antibiotics discontinuation or de-escalation (red square). This algorithm is described in . In both arms, at day 3 and day after day until day 7, clinicians are encouraged to consider antibiotic discontinuation, based on procalcitonin values and kinetics. CAP, community-acquired pneumonia; FA-PPP, FilmArray Pneumonia Panel Plus; ICU, intensive care unit; mPCR, multiplex PCR.

Article Snippet: In the experimental strategy arm, the microbiological diagnosis combines a broad-panel respiratory mPCR (FilmArray Pneumonia Panel Plus (FA-PPP), BioFire Biomérieux) with conventional microbiological investigations.

Techniques: Staining, Multiplex Assay

Algorithm of early antibiotics de-escalation or discontinuation. The algorithm is applied in the intervention arm only (see red square, ). mPCR, multiplex PCR; ICU, intensive care unit; PCT, procalcitonin.

Journal: BMJ Open

Article Title: Combined use of a broad-panel respiratory multiplex PCR and procalcitonin to reduce duration of antibiotics exposure in patients with severe community-acquired pneumonia (MULTI-CAP): a multicentre, parallel-group, open-label, individual randomised trial conducted in French intensive care units

doi: 10.1136/bmjopen-2020-048187

Figure Lengend Snippet: Algorithm of early antibiotics de-escalation or discontinuation. The algorithm is applied in the intervention arm only (see red square, ). mPCR, multiplex PCR; ICU, intensive care unit; PCT, procalcitonin.

Article Snippet: In the experimental strategy arm, the microbiological diagnosis combines a broad-panel respiratory mPCR (FilmArray Pneumonia Panel Plus (FA-PPP), BioFire Biomérieux) with conventional microbiological investigations.

Techniques: Multiplex Assay

Primary and secondary outcomes

Journal: BMJ Open

Article Title: Combined use of a broad-panel respiratory multiplex PCR and procalcitonin to reduce duration of antibiotics exposure in patients with severe community-acquired pneumonia (MULTI-CAP): a multicentre, parallel-group, open-label, individual randomised trial conducted in French intensive care units

doi: 10.1136/bmjopen-2020-048187

Figure Lengend Snippet: Primary and secondary outcomes

Article Snippet: In the experimental strategy arm, the microbiological diagnosis combines a broad-panel respiratory mPCR (FilmArray Pneumonia Panel Plus (FA-PPP), BioFire Biomérieux) with conventional microbiological investigations.

Techniques: Bacteria, Biomarker Discovery

 Multiplex PCR  and antimicrobial and diagnostic stewardship: key findings

Journal: Current Infectious Disease Reports

Article Title: Syndromic Multiplex Polymerase Chain Reaction (mPCR) Testing and Antimicrobial Stewardship: Current Practice and Future Directions

doi: 10.1007/s11908-021-00748-z

Figure Lengend Snippet: Multiplex PCR and antimicrobial and diagnostic stewardship: key findings

Article Snippet: Sensitivity for the BioFire FilmArray GI mPCR ranged from 94.5% for 7 of the 22 pathogens in the panel to 100% for 10 of 22 pathogens in one study.

Techniques: Multiplex Assay, Diagnostic Assay, Refining, Infection

Background.

Journal: Journal of Infection and Chemotherapy

Article Title: The impact analysis of a multiplex PCR respiratory panel for hospitalized pediatric respiratory infections in Japan

doi: 10.1016/j.jiac.2019.07.014

Figure Lengend Snippet: Background.

Article Snippet: We replaced rapid antigen tests with the mPCR respiratory panel (FilmArray®; Biofire, Utah, USA) as a microbiological diagnostic test for pediatric respiratory infections admitted since March 26, 2018.

Techniques: Biomarker Discovery

mPCR group chart.

Journal: Journal of Infection and Chemotherapy

Article Title: The impact analysis of a multiplex PCR respiratory panel for hospitalized pediatric respiratory infections in Japan

doi: 10.1016/j.jiac.2019.07.014

Figure Lengend Snippet: mPCR group chart.

Article Snippet: We replaced rapid antigen tests with the mPCR respiratory panel (FilmArray®; Biofire, Utah, USA) as a microbiological diagnostic test for pediatric respiratory infections admitted since March 26, 2018.

Techniques:

Outcomes.

Journal: Journal of Infection and Chemotherapy

Article Title: The impact analysis of a multiplex PCR respiratory panel for hospitalized pediatric respiratory infections in Japan

doi: 10.1016/j.jiac.2019.07.014

Figure Lengend Snippet: Outcomes.

Article Snippet: We replaced rapid antigen tests with the mPCR respiratory panel (FilmArray®; Biofire, Utah, USA) as a microbiological diagnostic test for pediatric respiratory infections admitted since March 26, 2018.

Techniques:

The number of pathogen detections by mPCR. Adeno; Adenovirus, Corona; Coronavirus HKU1, NL63, 229E or OC43, hMPV; human metapneumovirus, Rhino/Entero; Rhinovirus or Enterovirus, Flu; Influenza virus A, A H1, A H3, A H1-2009 or B, RS; Respiratory syncytial virus, Para; Parainfluenza virus 1, 2, 3 or 4, Mycoplasma; Mycoplasma Pneumoniae , Chlamydia; Chlamydia Pneumoniae , Pertussis; Bordetella pertussis .

Journal: Journal of Infection and Chemotherapy

Article Title: The impact analysis of a multiplex PCR respiratory panel for hospitalized pediatric respiratory infections in Japan

doi: 10.1016/j.jiac.2019.07.014

Figure Lengend Snippet: The number of pathogen detections by mPCR. Adeno; Adenovirus, Corona; Coronavirus HKU1, NL63, 229E or OC43, hMPV; human metapneumovirus, Rhino/Entero; Rhinovirus or Enterovirus, Flu; Influenza virus A, A H1, A H3, A H1-2009 or B, RS; Respiratory syncytial virus, Para; Parainfluenza virus 1, 2, 3 or 4, Mycoplasma; Mycoplasma Pneumoniae , Chlamydia; Chlamydia Pneumoniae , Pertussis; Bordetella pertussis .

Article Snippet: We replaced rapid antigen tests with the mPCR respiratory panel (FilmArray®; Biofire, Utah, USA) as a microbiological diagnostic test for pediatric respiratory infections admitted since March 26, 2018.

Techniques: Virus